DailyIQ
|
Sector:Consumer DefensiveAll sectors
Last updated 1 hour ago

CL·Colgate-Palmolive Company

$.
-. (-.%)
High
$91.47
Open
$91.21
Market Cap
73.50B
52W High
$99.33
Low
$89.44
P. Close
$91.66
P/E
35.22
52W Low
$74.55
Fwd P/E
22.47
Mean Target
$95.84
Technical Score (1D)
82
BUY
News Sentiment
49
MIXED
Fed Governor Lisa Cook indicated readiness to hike rates if inflation persists, citing rising oil prices, increased demand, and wage pressures as key drivers. This suggests a continued hawkish stance from the Fed, which could impact borrowing costs across the economy. Meanwhile, Citadel Securities also advocates for rate hikes, viewing inflation as a greater risk than the labor market and suggesting current Fed policy may be misaligned with economic growth. In related energy news, crude oil prices have retreated approximately 8% in the past week, partly on optimism surrounding a potential U.S.-Iran agreement that could ease supply concerns. This oil price decline has provided relief to airline stocks, which are sensitive to fuel costs. However, uncertainty remains regarding the Iran deal, with President Trump emphasizing the need to avoid rushing negotiations and highlighting unresolved issues like the Strait of Hormuz and Iran's nuclear program. The U.S. Treasury has also allowed a waiver for Russian oil purchases to expire, which could further influence global crude availability. For Colgate-Palmolive (CL), recent performance has been strong, with Q1 revenue increasing 8.4% year-over-year and the company announcing its 63rd consecutive dividend increase. CL's innovation strategy, focusing on premium and science-backed products, is driving market share gains in both oral care and pet nutrition. Despite some bearish price targets, analysts generally view CL favorably, with several reiterating Overweight ratings and raising price targets, citing strong organic sales growth potential and emerging market exposure. The stock's momentum indicators are improving, and shares have recovered from recent lows, suggesting upside potential. Investors should monitor upcoming commentary from CL executives at the dbAccess Global Consumer Conference for further insights into company strategy and outlook.
Earnings Summary
Colgate-Palmolive is a global consumer goods company operating in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company's business is divided into Oral, Personal and Home Care, and Pet Nutrition segments, featuring well-known brands like Colgate, Palmolive, and Hill's Science Diet, and it maintains a broad distribution network. In its most recent reported quarters, Colgate-Palmolive demonstrated consistent performance, with Q1 2026 EPS of $0.97 beating estimates and revenue of $5.324 billion also exceeding expectations. This follows a Q4 2025 where EPS was $0.95 against an estimate of $0.9395 and revenue of $5.23 billion was slightly below the estimate of $5.272 billion. Prior to this, Q3 2025 saw EPS of $0.91 against an estimate of $0.889, and Q2 2025 reported EPS of $0.92 against an estimate of $0.895. The company has shown a pattern of beating EPS estimates in recent quarters, with revenue trends showing a general increase, though with some quarters missing revenue targets. Looking at its historical streak, Colgate-Palmolive has generally exhibited year-over-year revenue growth, with recent quarters showing positive trends in both EPS and revenue, often exceeding analyst expectations. For instance, the Q1 2026 results indicated strong year-over-year revenue growth of 8.4% and an EPS beat. Recent news highlights Colgate-Palmolive's participation in the dbAccess Global Consumer Conference, offering insights into strategic direction, and notes positive technical momentum for its shares supported by strong brand awareness. Furthermore, a recent Q1 earnings beat was reported with significant year-over-year revenue growth and a dividend hike, underscoring financial health. Investors should watch for the company's ability to maintain its organic sales growth potential, particularly in emerging markets, and monitor the impact of potential tariffs on North American margins and broader geopolitical influences on energy markets, which could indirectly affect consumer spending and input costs.

EPS

EstBeatMiss
$0.84$0.88$0.91$0.95$0.99Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$0.95 - -
Q1'26$0.96$0.97+1.4%
Q4'25$0.94$0.95+1.1%
Q3'25$0.89$0.91+2.4%
Q2'25$0.89$0.92+2.8%
Q1'25$0.86$0.91+6.1%

Revenue

EstBeatMiss
$4.8B$5.0B$5.2B$5.4B$5.6BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$5.5B - -
Q1'26$5.3B$5.3B-0.2%
Q4'25$5.3B$5.2B-0.8%
Q3'25 - $5.1B -
Q2'25 - $5.1B -
Q1'25 - $4.9B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

CL Stock Snapshot

CL is currently trading at $90.85, giving Colgate-Palmolive Company a market cap of 73.50B and a P/E ratio of 35.2. Today's range spans $89.44–$91.47, with shares opening at $91.21 and moving down $0.81 (0.9%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 49/100.

Over the past year CL has traded between $74.55 and $99.33 - the current price is +21.9% off the 52-week low and -8.5% from the high. 31 analysts cover the stock with a Buy consensus and a mean 12-month target of $95.84 (range $80.00–$105.00), implying upside of +5.5%.

The breakout geometry on CL is constructive - price at $90.85 (in the middle of its 52-week range in $74.55–$99.33), scoring 82/100 (BUY) with neutral sentiment (49/100). (P/E: 35.2) At 73.50B in Consumer Defensive market cap, technical breakouts through prior resistance at this capitalization tier tend to be better validated than in smaller-cap peers - institutional participation means that cleared levels attract follow-through buying rather than immediate fade behavior.

The combination of a BUY signal (82/100) and neutral news sentiment (49/100) puts CL on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 73.50B in Consumer Defensive market cap without immediately moving the stock. At $90.85 (in the middle of its 52-week range in the $74.55–$99.33 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.